Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00799435 · ClinicalTrials.gov registry record · Phase 4
Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure
A Phase 4 study, sponsored by Baylor College of Medicine.
- Terminated
- Registry status
- Phase 4
- Development phase
- 2
- Enrollment target
NCT00799435 is a Phase 4 study that was terminated before completion, run by Baylor College of Medicine. The registered enrollment target is 2 participants.
The verdict
NCT00799435, a Phase 4 study, was terminated before completion, sponsored by Baylor College of Medicine.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 2 participants
- Enrollment target
Study Summary
People with type 2 diabetes experience heart failure more often than do people without diabetes. This may be due to increased stiffness in the heart as a result of diabetes. This study will examine whether exenatide, a medication used to treat diabetes, may have beneficial effects on the heart in people with type 2 diabetes and heart failure.
Interventions
- DRUG Exenatide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2009-07 |
| Est. Completion | 2012-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00799435
The ClinicalTrials.gov registry entry for NCT00799435 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Exenatide is the first listed.
NCT00799435 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00799435 about?
NCT00799435 is a clinical study titled "Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure". People with type 2 diabetes experience heart failure more often than do people without diabetes. This may be due to increased stiffness in the heart as a result of diabetes. This study will examine whether exenatide, a medication used to treat diabetes, may have beneficial effects on the heart in pe...
What is the current status of trial NCT00799435?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 2 participants. The study started on 2009-07. Estimated completion is 2012-04.
What interventions are being tested in trial NCT00799435?
The interventions under investigation include: Exenatide (DRUG).
Who is sponsoring clinical trial NCT00799435?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.